Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$283.36
-0.9%
$277.84
$190.75
▼
$302.93
$500.87B0.26.27 million shs5.05 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$19.31
$18.51
$14.06
▼
$20.13
$37.09B0.4818.80 million shsN/A
PepsiCo, Inc. stock logo
PEP
PepsiCo
$139.00
-2.0%
$133.99
$123.47
▼
$171.48
$189.42B0.318.30 million shs8.78 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-2.22%-3.06%+1.05%+9.18%+22.28%
Kenvue Inc. stock logo
KVUE
Kenvue
0.00%0.00%+2.36%+2.06%+18.50%
PepsiCo, Inc. stock logo
PEP
PepsiCo
-0.11%-1.44%+6.21%-0.15%-4.64%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$283.36
-0.9%
$277.84
$190.75
▼
$302.93
$500.87B0.26.27 million shs5.05 million shs
Kenvue Inc. stock logo
KVUE
Kenvue
$19.31
$18.51
$14.06
▼
$20.13
$37.09B0.4818.80 million shsN/A
PepsiCo, Inc. stock logo
PEP
PepsiCo
$139.00
-2.0%
$133.99
$123.47
▼
$171.48
$189.42B0.318.30 million shs8.78 million shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-2.22%-3.06%+1.05%+9.18%+22.28%
Kenvue Inc. stock logo
KVUE
Kenvue
0.00%0.00%+2.36%+2.06%+18.50%
PepsiCo, Inc. stock logo
PEP
PepsiCo
-0.11%-1.44%+6.21%-0.15%-4.64%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.83
Moderate Buy$299.625.74% Upside
Kenvue Inc. stock logo
KVUE
Kenvue
2.00
Hold$19.29-0.13% Downside
PepsiCo, Inc. stock logo
PEP
PepsiCo
2.19
Hold$142.942.84% Upside

Current Analyst Ratings Breakdown

Latest PEP, ABBV, and KVUE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Set Price TargetOverweight$349.00
11/18/2026
PepsiCo, Inc. stock logo
PEP
PepsiCo
Initiated CoveragePeer Perform
11/17/2026
PepsiCo, Inc. stock logo
PEP
PepsiCo
DowngradeMarket Perform ➝ Underperform$131.00 ➝ $128.00
11/16/2026
PepsiCo, Inc. stock logo
PEP
PepsiCo
UpgradeHold (C-) ➝ Hold (C)
11/16/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOverweight$325.00 ➝ $335.00
11/4/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Set Price Target$315.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Reiterated RatingMarket Perform$275.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetBuy$288.00 ➝ $322.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOverweight$300.00 ➝ $340.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetNeutral$275.00 ➝ $295.00
11/2/2026
AbbVie Inc. stock logo
ABBV
AbbVie
Boost Price TargetOutperform$309.00 ➝ $342.00
(Data available from 11/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$61.16B8.19$14.66 per share19.33($2.57) per share-110.26
Kenvue Inc. stock logo
KVUE
Kenvue
$15.53B2.39$1.38 per share14.02$5.62 per share3.44
PepsiCo, Inc. stock logo
PEP
PepsiCo
$93.93B2.02$11.00 per share12.64$16.50 per share8.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.23B$5.8148.7717.691.3315.67%-450.55%16.50%2/3/2027 (Estimated)
Kenvue Inc. stock logo
KVUE
Kenvue
$1.47B$0.8821.9415.831.7710.76%21.22%8.37%N/A
PepsiCo, Inc. stock logo
PEP
PepsiCo
$8.24B$7.9617.4616.094.2311.09%53.08%10.42%2/2/2027 (Estimated)

Latest PEP, ABBV, and KVUE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/30/2026Q3 2026
AbbVie Inc. stock logo
ABBV
AbbVie
$3.73$3.82+$0.09$2.37$17.32 billion$17.40 billion
10/30/2026Q3 2026
Kenvue Inc. stock logo
KVUE
Kenvue
$0.2915$0.29-$0.0015$0.22$3.86 billion$3.89 billion
10/7/2026Q3 2026
PepsiCo, Inc. stock logo
PEP
PepsiCo
$2.29$2.34+$0.05$2.23$24.95 billion$25.27 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.922.44%+6.80%119.10%53 Years
Kenvue Inc. stock logo
KVUE
Kenvue
$0.844.35%N/A95.45%1 Years
PepsiCo, Inc. stock logo
PEP
PepsiCo
$5.924.27%+6.93%74.37%54 Years

Latest PEP, ABBV, and KVUE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/29/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.822.47%1/15/20271/15/20272/16/2027
11/18/2026
PepsiCo, Inc. stock logo
PEP
PepsiCo
quarterly$1.484.17%12/4/202612/4/20261/6/2027
9/10/2026
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.732.44%10/15/202610/15/202611/16/2026
9/10/2026
Kenvue Inc. stock logo
KVUE
Kenvue
quarterly$0.214.75%9/21/20269/21/202610/2/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
N/A
0.87
0.75
Kenvue Inc. stock logo
KVUE
Kenvue
0.67
1.01
0.71
PepsiCo, Inc. stock logo
PEP
PepsiCo
1.90
0.94
0.76

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Kenvue Inc. stock logo
KVUE
Kenvue
97.64%
PepsiCo, Inc. stock logo
PEP
PepsiCo
73.07%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.06%
Kenvue Inc. stock logo
KVUE
Kenvue
1.59%
PepsiCo, Inc. stock logo
PEP
PepsiCo
0.12%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
57,0001.77 billion1.77 billionOptionable
Kenvue Inc. stock logo
KVUE
Kenvue
22,0001.92 billion1.89 billionOptionable
PepsiCo, Inc. stock logo
PEP
PepsiCo
306,0001.36 billion1.36 billionOptionable

Recent News About These Companies

How KFC Partnership Loss Will Impact PepsiCo (PEP) Investors
Bernstein Sees Trouble Ahead for PepsiCo (PEP). Here’s Where.
Bernstein Sees Trouble Ahead for PepsiCo (PEP). Here’s Where.
PepsiCo Romania taps Rezolv for power from 431-MW Vifor wind farm
NIQ Appoints Danny Lange and Chris Tung to Board of Directors
PepsiCo (NASDAQ:PEP) Stock Gets Downgrade from Sanford C. Bernstein
Bernstein Sees 13% Downside in PepsiCo
PepsiCo launches proprietary syrup lineup, concentrated bases
PepsiCo Declares Quarterly Dividend
PepsiCo Declares Quarterly Dividend
PepsiCo improves deforestation-free sourcing for key commodities

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$283.36 -2.65 (-0.93%)
Closing price 03:59 PM Eastern
Extended Trading
$282.15 -1.21 (-0.43%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Kenvue stock logo

Kenvue NYSE:KVUE

$19.31 0.00 (0.00%)
As of 11/6/2026

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

PepsiCo stock logo

PepsiCo NASDAQ:PEP

$139.00 -2.87 (-2.02%)
Closing price 04:00 PM Eastern
Extended Trading
$139.32 +0.32 (+0.23%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products, as well as distributes alcoholic beverages under Hard MTN Dew brand. The company offers its products primarily under the Lay's, Doritos, Fritos, Tostitos, BaiCaoWei, Cheetos, Cap'n Crunch, Life, Pearl Milling Company, Gatorade, Pepsi-Cola, Mountain Dew, Quaker, Rice-A-Roni, Aquafina, Bubly, Emperador, Diet Mountain Dew, Diet Pepsi, Gatorade Zero, Crush, Propel, Dr Pepper, Schweppes, Marias Gamesa, Ruffles, Sabritas, Saladitas, Tostitos, 7UP, Diet 7UP, H2oh!, Manzanita Sol, Mirinda, Pepsi Black, Pepsi Max, San Carlos, Toddy, Walkers, Chipsy, Kurkure, Sasko, Spekko, White Star, Smith's, Sting, SodaStream, Lubimyj Sad, Agusha, Chudo, Domik v Derevne, Lipton, and other brands. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is based in Purchase, New York.